Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2018
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma
Yihebali Chi, Zhiwei Fang, Xiaonan Hong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 21, 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
Wang Qu, Cheng Fu, Weiqing Han, et al.
Liver Cancer
|
June 23, 2025
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma
Xinyu Bi, Yinying Lu, Bo Chen, et al.
Frontiers in Immunology
|
August 20, 2025
Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients
Yirui Zhai, Yefan Zhang, Fan Wu, et al.
Cancer Medicine
|
April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single Center
Lingxia Xin, Zhiyu Li, Yirui Zhai, et al.
The Oncologist
|
June 9, 2021
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)
Yihebali Chi, Yongqian Shu, Yi Ba, et al.
Innovation (Cambridge (Mass.))
|
July 9, 2026
Chinese consensus on first-line precision therapy for advanced gastric cancer
Xiaotian Zhang, Weiqi Sheng, Tong Xie, et al.
Liver Cancer
|
August 11, 2022
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements
Yongkun Sun, Wen Zhang, Xinyu Bi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 17, 2021
Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
Hong Zhao, Aiping Zhou, Jianguo Zhou, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2018
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma
Yihebali Chi, Zhiwei Fang, Xiaonan Hong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 21, 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
Wang Qu, Cheng Fu, Weiqing Han, et al.
Liver Cancer
|
June 23, 2025
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma
Xinyu Bi, Yinying Lu, Bo Chen, et al.
Frontiers in Immunology
|
August 20, 2025
Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients
Yirui Zhai, Yefan Zhang, Fan Wu, et al.
Cancer Medicine
|
April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single Center
Lingxia Xin, Zhiyu Li, Yirui Zhai, et al.
The Oncologist
|
June 9, 2021
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)
Yihebali Chi, Yongqian Shu, Yi Ba, et al.
Innovation (Cambridge (Mass.))
|
July 9, 2026
Chinese consensus on first-line precision therapy for advanced gastric cancer
Xiaotian Zhang, Weiqi Sheng, Tong Xie, et al.
Liver Cancer
|
August 11, 2022
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements
Yongkun Sun, Wen Zhang, Xinyu Bi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 17, 2021
Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
Hong Zhao, Aiping Zhou, Jianguo Zhou, et al.
Page
of 8